Takeda Pharmaceutical (Germany) Price Prediction

TKD Stock  EUR 25.01  0.12  0.48%   
As of 21st of December 2024, The value of RSI of Takeda Pharmaceutical's share price is at 54. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Takeda Pharmaceutical, making its price go up or down.

Oversold Vs Overbought

54

 
Oversold
 
Overbought
The successful prediction of Takeda Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Takeda Pharmaceutical and does not consider all of the tangible or intangible factors available from Takeda Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Takeda Pharmaceutical, which may create opportunities for some arbitrage if properly timed.
Using Takeda Pharmaceutical hype-based prediction, you can estimate the value of Takeda Pharmaceutical from the perspective of Takeda Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Takeda Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Takeda because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Takeda Pharmaceutical after-hype prediction price

    
  EUR 25.01  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
22.3823.4827.51
Details
Naive
Forecast
LowNextHigh
23.6424.7425.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
24.8725.5026.13
Details

Takeda Pharmaceutical After-Hype Price Prediction Density Analysis

As far as predicting the price of Takeda Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Takeda Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Takeda Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Takeda Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Takeda Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Takeda Pharmaceutical's historical news coverage. Takeda Pharmaceutical's after-hype downside and upside margins for the prediction period are 23.91 and 26.11, respectively. We have considered Takeda Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
25.01
25.01
After-hype Price
26.11
Upside
Takeda Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Takeda Pharmaceutical is based on 3 months time horizon.

Takeda Pharmaceutical Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Takeda Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Takeda Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Takeda Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.08 
1.10
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
25.01
25.01
0.00 
0.00  
Notes

Takeda Pharmaceutical Hype Timeline

Takeda Pharmaceutical is at this time traded for 25.01on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Takeda is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.08%. %. The volatility of related hype on Takeda Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 25.01. About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.58. The entity last dividend was issued on the 30th of March 2023. Assuming the 90 days horizon the next estimated press release will be within a week.
Check out Takeda Pharmaceutical Basic Forecasting Models to cross-verify your projections.

Takeda Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Takeda Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Takeda Pharmaceutical's future price movements. Getting to know how Takeda Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Takeda Pharmaceutical may potentially react to the hype associated with one of its peers.

Takeda Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Takeda price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Takeda using various technical indicators. When you analyze Takeda charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Takeda Pharmaceutical Predictive Indicators

The successful prediction of Takeda Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Takeda Pharmaceutical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Takeda Pharmaceutical based on analysis of Takeda Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Takeda Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Takeda Pharmaceutical's related companies.

Story Coverage note for Takeda Pharmaceutical

The number of cover stories for Takeda Pharmaceutical depends on current market conditions and Takeda Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Takeda Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Takeda Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Takeda Pharmaceutical Short Properties

Takeda Pharmaceutical's future price predictability will typically decrease when Takeda Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Takeda Pharmaceutical often depends not only on the future outlook of the potential Takeda Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Takeda Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 B

Complementary Tools for Takeda Stock analysis

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency